Renvela
Pricing Report NDC 58468-0130-1

Latest NADAC: $5.70806 per EA · Effective Oct 22, 2025 · Est. package price $1,541.18 (270 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Renvela (NDC 58468-0130-1) is $5.70806 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Oct 22, 2025.

As a provided by Genzyme Corporation, this medication is distributed in a 270 TABLET, FILM COATED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$5.70806
Per EA

Effective Date
Oct 22, 2025
Billable Units
270 EA
Estimated Package Price
$1,541.18
Data Status
As of Oct 29, 2025
C/I - Chain or Independent Pharmacy
Package NDC
Description
270 TABLET, FILM COATED in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $0.22216 (Effective: Oct 22, 2025)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2013, the NADAC wholesale price for (NDC ) has moved within a range of $3.09270 to $5.77811 per EA. Over this 12 years period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$3.0927 - $5.7781
Market Volatility
86.83% Variance
Latest Trend
0.04%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Oct 22, 2025 $5.70806 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 17, 2025 $5.71055 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 20, 2025 $5.70829 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 23, 2025 $5.71336 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 18, 2025 $5.71410 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 21, 2025 $5.71238 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 23, 2025 $5.71448 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 19, 2025 $5.71318 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 19, 2025 $5.71601 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 22, 2025 $5.71491 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 18, 2024 $5.71519 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 20, 2024 $5.71329 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026